Blog
Utility of the VRFCAT in Parkinson’s Disease
VeraSci developed the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) to assess proficiency in performing real-world tasks in a realistic environment. The VRFCAT, a digital tablet-based instrument, has been accepted into the FDA clinical outcome...
ISCTM Brings Together FDA & Industry for Working Group on Adapting Trials for Remote Assessment
The Innovative Technologies Working Group of the International Society for CNS Clinical Trials and Methodology (ISCTM) held two special meetings to discuss challenges related to implementing remote assessments in CNS clinical trials in the context of COVID-19...
Common Developmental and Cognitive Assessments in Pediatric Rare Disease Clinical Trials
Many rare disease indications are studied predominantly, if not entirely, in pediatric populations. For many products, one or more of the key secondary endpoints will involve the use of developmental and cognitive assessments. These specific types of assessments are...
Facing the Challenge: Communication is Critical
The COVID-19 pandemic and associated social distancing measures are creating unprecedented challenges for everyone working in clinical trials and drug development. In this series, we’re sharing some of the ways VeraSci is addressing these challenges. As we coordinate...
Welcome to the Innovation Lab
The VeraSci Innovation Lab was created to pair scientific knowledge with cutting-edge technology to improve the tools and measurements available for use in clinical trials. Each innovation is rigorously validated to ensure their usefulness in drug development...
Understanding the Difference Between Centralized Review, Centralized Scoring, and Remote Administration
Social distancing requirements based on COVID-19 have left many sponsors looking for alternatives to in-person study visits for both on-going clinical trials and clinical trials planning to start soon. As we’ve been having conversations with sponsors about their...
Facing the Challenge: How to Conduct Remote Cognitive Assessments
The COVID-19 pandemic and associated social distancing measures are creating unprecedented challenges for everyone working in clinical trials and drug development. In this series, we’re sharing some of the ways VeraSci is addressing these challenges. With...
Selecting Outcome Assessments in Multiple Sclerosis
Multiple sclerosis is a complex disease that presents numerous challenges in selecting appropriate measurements for a given clinical trial. These challenges can include: Handling inflammation and relapses versus degeneration and progression A lack of...
Facing the Challenge: Remote Motor Assessments
The COVID-19 pandemic and associated social distancing measures are creating unprecedented challenges for everyone working in clinical trials and drug development. In this series, we’re sharing some of the ways VeraSci is addressing these challenges. With...
Unprecedented Challenges Call for Exceptional Solutions
Facing the Challenge: Remote Assessments for Clinical Trials During the COVID-19 Pandemic The COVID-19 pandemic and associated social distancing measures are creating unprecedented challenges for everyone working in clinical trials and drug development....